Injective is showing renewed bullish momentum after reclaiming key support, with analysts eyeing a potential move higher if buying strength continues. Meanwhile, Canary Capital’s updated Staked INJ ETF filing adds optimism, introducing improved staking transparency and custody measures as regulatory progress advances.
